ClinicalTrials.Veeva

Menu

Scaling Up NCD Interventions in South East Asia (SUNI-SEA)

U

University Medical Center Groningen (UMCG)

Status

Completed

Conditions

Hypertension
Cardiovascular Diseases
Diabetes Mellitus, Type 2

Treatments

Combination Product: screening, prevention and counselling

Study type

Interventional

Funder types

Other

Identifiers

NCT05239572
202100908

Details and patient eligibility

About

The SUNI-SEA study is an intervention study that measures effectiveness and cost-effectiveness of prevention and early diagnosis of diabetes and cardiovascular diseases in communities and primary healthcare (PHC) facilities in Indonesia, Myanmar and Vietnam.

Full description

The study takes place in Vietnam and Indonesia in Intergenerational Self-Help Clubs (ISHGs), where community members assemble for activities concerning social, economical improvement and health and well-being. Volunteers in these ISHGs are trained in performing screening for diabetes and cardiovascular diseases and counselling participants concerning healthy living, or referral to primary healthcare facilities, if needed. At PHC level further diagnosis and if needed treatment is provided and referral back to ISHGs is done for lifestyle interventions.

In Indonesia screening takes place in the Posbindu programme, where trained volunteers (cadres) screen and counsel participants. If needed referral to Puskesmas (primary healthcare facilities is done, where further diagnosis and treatment takes place. Activities for health promotion and lifestyle interventions take place under supervision of the Posbindu programme.

In Myanmar and Indonesia individual monitoring and health education of participants is done through mobile applications.

Measuring of uptake, follow-up and adherence to interventions is done through routine data collection, through surveys, and through semi-structured interviews and focus group discussions.

Enrollment

16,850 patients

Sex

All

Ages

21+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All adults living in geographical area where research takes place

Exclusion criteria

  • Persons who are not able to come to location of screening, due to illness or other chronic condition causing immobility.

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

16,850 participants in 1 patient group

Screening and early detection of diabetes and cardiovascular diseases
Experimental group
Description:
Screening for NCDs based on questionnaire concerning vital information, lifestyle, simple measures of length, bodyweight, BMI, blood pressure, application of FinRisk score and WHO risk score. Health promotion and lifestyle counselling and referral to PHC facilities for further diagnosis and treatment.
Treatment:
Combination Product: screening, prevention and counselling

Trial contacts and locations

1

Loading...

Central trial contact

Hanneke Vervoort, MSc; Jaap Koot, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems